Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

Market Cap	26.76M
Revenue (ttm)	5.10M
Net Income (ttm)	-3.53M
Shares Out	137.21M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	116,000
Average Volume	53,810
Open	0.2000
Previous Close	0.2100
Day's Range	0.1950 - 0.2000
52-Week Range	0.1450 - 0.4000
Beta	0.68
RSI	44.42
Earnings Date	Aug 20, 2025

About Accolade

Malaysian Genomics Resource Centre Berhad, together with its subsidiaries, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide. Its flagship product, Dtect genetic screening tests which inspects DNA for markers associated with genetic variations that influence various biological processes. The company also offers genome sequencing services for humans, animals, plants, and microbes and other living organisms; transcriptome sequencing; and metagenomics and metatranscriptomics. In addition, it provides genome analy...

• Industry: Commercial Physical and Biological Research
• Founded: 2004
• Employees: 16
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: MGRC

Financial Performance

In 2024, KLSE:MGRC's revenue was 5.52 million, a decrease of -42.32% compared to the previous year's 9.57 million. Losses were -4.19 million, -78.00% less than in 2023.